Tweet by JAMA Neurology on Twitter Posted byJoseph Thornton MDFebruary 9, 2023Posted inBlog JAMA Neurology @JAMANeuro In this study, plasma P-tau217 predicted cognitive decline in patients with preclinical #AlzheimerDisease. ja.ma/3Xd8NPI 2/8/23, 12:00 PM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor, [AIdvisor] Retired Clinical Associate Professor, Psychiatry, University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts